^
No biomarker
Marginal Zone Lymphoma
umbralisib
Sensitive
:
A1
No biomarker
Marginal Zone Lymphoma
ibrutinib
Sensitive
:
A1
No biomarker
Marginal Zone Lymphoma
R-CVP
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
R-CHOP
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
rituximab + lenalidomide
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
rituximab
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
axicabtagene ciloleucel
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
obinutuzumab
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
idelalisib
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
duvelisib
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
copanlisib
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
cyclophosphamide oral
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
chlorambucil
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
ibritumomab tiuxetan
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
lenalidomide + obinutuzumab
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
G-CHOP
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
lisocabtagene maraleucel
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
tisagenlecleucel-T
Sensitive
:
A2
No biomarker
Marginal Zone Lymphoma
O-CVP
Sensitive
:
A2
MYD88 mutation
Marginal Zone Lymphoma
ibrutinib
Sensitive
:
C3
CARD11 mutation
Marginal Zone Lymphoma
ibrutinib
Resistant
:
C3
KMT2D mutation
Marginal Zone Lymphoma
ibrutinib
Resistant
:
C3
MYD88 L265P
Marginal Zone Lymphoma
ibrutinib
Sensitive
:
C3
TNFAIP3 mutation
Marginal Zone Lymphoma
ibrutinib
Sensitive
:
C3
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our